Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -6.33% is 43% above its 5-year average of -11.04%, near the high end of its 5-year range (-25.27%–1.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.85% above its 12-month average of -6.58%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -6.33%.
RETURN ON INVESTED CAPITAL (ROIC)
-6.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-6.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-5.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-11.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.85%
CURRENT VS 3Y AVG
-7.78%
CURRENT VS 5Y AVG
+42.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
+79.99%
vs the sector median at left
Castle Biosciences, Inc.
Market Cap
$1.11B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-6.58%
3Y Avg
-5.87%
5Y Avg
-11.04%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
5.93%
TTM Avg
9.95%
3Y Avg
11.37%
5Y Avg
9.31%
Market Cap
$1.10B
Return on Invested Capital (ROIC)
20.18%
TTM Avg
20.20%
3Y Avg
19.35%
5Y Avg
14.75%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
-42.98%
TTM Avg
-26.82%
3Y Avg
-23.95%
5Y Avg
-23.95%
Market Cap
$1.14B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.83%
3Y Avg
4.30%
5Y Avg
3.30%
Market Cap
$1.16B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
3.50%
3Y Avg
1.32%
5Y Avg
-2.22%
Market Cap
$1.17B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.04B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$1.03B
Return on Invested Capital (ROIC)
0.86%
TTM Avg
2.66%
3Y Avg
2.26%
5Y Avg
2.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Castle Biosciences, Inc. (CSTL) | $1.11B | -6.33% | -6.58% | -5.87% | -11.04% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 5.93% | 9.95% | 11.37% | 9.31% |
| IRadimed Corporation (IRMD)vs › | $1.10B | 20.18% | 20.20% | 19.35% | 14.75% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.12B | -42.98% | -26.82% | -23.95% | -23.95% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 1.81% | 7.83% | 4.30% | 3.30% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 3.72% | 3.50% | 1.32% | -2.22% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.17B | -67.73% | -67.73% | -67.73% | -67.73% |
| Teladoc Health, Inc. (TDOC)vs › | $1.04B | -7.32% | -21.18% | -91.27% | -61.58% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | 0.86% | 2.66% | 2.26% | 2.26% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.19B | -52.44% | -96.82% | -100.85% | -77.97% |
ROIC
-6.3%
ROE
-4.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -6.33% |
| 2026-03-31 | -6.65% |
| 2025-12-31 | -8.39% |
| 2025-09-30 | -6.88% |
| 2025-06-30 | -4.65% |
| 2025-03-31 | -2.96% |
| 2024-12-31 | 1.52% |
| 2024-09-30 | -0.12% |
| 2024-06-30 | -3.52% |
| 2024-03-31 | -9.83% |
| 2023-12-31 | -16.76% |
| 2023-09-30 | -21.30% |
| 2023-06-30 | -24.78% |
| 2023-03-31 | -25.27% |
| 2022-12-31 | -22.68% |
| 2022-09-30 | -20.10% |
| 2022-06-30 | -17.61% |
| 2022-03-31 | -14.90% |
| 2021-12-31 | -9.16% |
| 2021-09-30 | -6.77% |
| 2021-06-30 | -4.80% |
| 2021-03-31 | -2.83% |
| 2020-12-31 | -1.56% |
| 2020-09-30 | -0.47% |
| 2020-06-30 | 2.23% |
| 2020-03-31 | 4.21% |
| 2019-12-31 | 3.65% |
| 2019-09-30 | 4.86% |
| 2019-06-30 | 8.20% |
| 2019-03-31 | -3.66% |
| 2018-12-31 | -24.48% |
